Provided by Tiger Trade Technology Pte. Ltd.

Bristol-Myers Squibb

62.40
-0.4600-0.73%
Post-market: 62.450.0487+0.08%19:59 EDT
Volume:15.87M
Turnover:998.92M
Market Cap:127.03B
PE:13.74
High:64.13
Open:63.28
Low:62.40
Close:62.86
52wk High:68.64
52wk Low:42.52
Shares:2.04B
Float Shares:2.03B
Volume Ratio:1.11
T/O Rate:0.78%
Dividend:2.51
Dividend Rate:4.02%
EPS(TTM):4.54
EPS(LYR):3.46
ROE:46.60%
ROA:10.72%
PB:5.69
PE(LYR):18.03

Loading ...

Bristol Myers Squibb Co. Stock Underperforms Tuesday When Compared to Competitors

Dow Jones
·
Sep 09

Bristol-Myers Squibb Co Stock (BMY) Moved Down by 3.25% on Sep 8: Facts Behind the Movement

TradingKey
·
Sep 09

Movement Alert|Bristol-Myers Squibb Falls 3.05% in Regular Trading, CAR-T Safety Concerns Across Sector Offset Positive Clinical Data

Market Focus
·
Sep 08

Bristol Myers Squibb's Phase 2 Study of Arlocabtagene Autoleucel Meets Key Endpoints

MT Newswires Live
·
Sep 08

Bristol Myers’ arlocabtagene autoleucel shows positive results in Phase 2 trial

TIPRANKS
·
Sep 08

Bristol Myers Squibb's Therapy Meets Mid-Stage Trial Goal

Reuters
·
Sep 08

Bristol Myers Squibb Announces Positive Topline Results from Registrational Phase 2 Quintessential Trial of the Potential First-in-Class Gprc5d-Directed Car T Cell Therapy, Arlocabtagene Autoleucel ...

THOMSON REUTERS
·
Sep 08

Bristol-Myers Squibb Company - Phase 2 Trial Met Primary Endpoint of Overall Response Rate and Complete Response Rate

THOMSON REUTERS
·
Sep 08

Bristol-Myers Squibb Company - Arlo-Cel Safety Profile Consistent with Other Car T Cell Therapies

THOMSON REUTERS
·
Sep 08

Jeito Capital Promotes Pascal Touchon to Partner

Reuters
·
Sep 08

Berenberg Bank Sticks to Its Buy Rating for Bloomsbury Publishing (BMY)

TIPRANKS
·
Sep 08

Bristol Myers Squibb Co. Stock Underperforms Friday When Compared to Competitors

Dow Jones
·
Sep 05

Bristol-Myers Squibb Moves Into Depression Market With New Phase 2 Trial

TIPRANKS
·
Sep 05

Drugmakers Halt Autoimmune Trials After Deaths, Life-Threatening Side Effects

Dow Jones
·
Sep 04

Market Chatter: Bristol Myers Squibb Paused Zola-Cel Trials Over Safety Concerns

MT Newswires Live
·
Sep 04

Dow Jones Top Company Headlines at 11 PM ET: the 'Deeply Nerdy' Founders Behind Nvidia's $13 Billion Bet on Hugging Face | Musk's ...

Dow Jones
·
Sep 04

Eikon Therapeutics Names Ching-Pin Chang as Chief Scientific Officer

Reuters
·
Sep 03

Revisiting Stock Picks Dexcom, Bristol Myers Squibb, Quanta Services

Dow Jones
·
Sep 03

Bristol Myers Squibb Co. Stock Underperforms Wednesday When Compared to Competitors Despite Daily Gains

Dow Jones
·
Sep 03

London Midcaps Lead Losses as Rising Gilt Yields Weigh; Reckitt Gains

Reuters
·
Sep 02